Embecta Corp

NAS:EMBCHealthcareCBOEFTSE:MRUTnasdaq_composite

$6.21−0.96%At closeAt close · Tue 20 Oct · ≈ AED 22.81 · Market cap $351.86M · Next earnings Tue 1 Dec

EMBC · Income statement · TradingHolo

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	1.1	1.2	1.1	1.1	1.1	1.1	1.0	−5.7%
Cost of revenue	0.3	0.4	0.4	0.4	0.4	0.4	0.4	+0.6%
Gross profit	0.8	0.8	0.8	0.7	0.7	0.7	0.6	−9.5%
Research & development	0.1	0.1	0.1	0.1	0.1	0.0	0.0	−26.0%
Selling, general & administrative	0.2	0.2	0.3	0.3	0.4	0.3	—	—
Selling & marketing	0.2	0.2	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.3	0.3	0.4	0.5	0.6	0.4	0.4	+7.9%
Operating income	0.5	0.5	0.4	0.2	0.2	0.3	0.2	−27.9%
Interest expense	0.0	0.0	0.0	0.1	0.1	0.1	0.1	−9.9%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	(0.0)	0.0	(0.1)	(0.1)	(0.1)	(0.2)	—	—
Pre-tax income	0.5	0.5	0.3	0.1	0.0	0.1	0.1	−8.3%
Income tax	0.1	0.1	0.0	0.0	(0.0)	0.0	0.0	−8.3%
Net income	0.4	0.4	0.2	0.1	0.1	0.1	0.1	−8.3%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	(0.0)	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	7.50	7.31	3.92	1.23	1.36	1.64	1.49	−9.1%
EPS, diluted (per share)	7.50	7.31	3.89	1.22	1.34	1.62	1.48	−8.7%
EBITDA	0.5	0.5	0.3	0.2	0.2	0.3	0.3	−8.4%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.1	0.0	−8.4%
Weighted average shares (shares)	57,000,000	56,804,716	57,055,327	57,235,772	58,432,835	58,309,000	—	—
Weighted average diluted shares (shares)	57,000,000	56,804,716	57,055,327	57,758,000	58,326,000	58,915,000	—	—
Gross margin	70.3%	68.7%	68.6%	66.9%	64.9%	62.9%	60.4%	−2.5 pts
Operating margin	44.9%	42.2%	33.5%	20.5%	15.5%	30.5%	23.3%	−7.2 pts
Net margin	39.4%	35.6%	19.8%	6.3%	7.0%	8.8%	8.6%	−0.2 pts

USD billionsUpdated Fri 7 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.